K. Squires

2.3k total citations
22 papers, 948 citations indexed

About

K. Squires is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, K. Squires has authored 22 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 10 papers in Virology and 10 papers in Epidemiology. Recurrent topics in K. Squires's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (10 papers). K. Squires is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and HIV/AIDS Research and Interventions (10 papers). K. Squires collaborates with scholars based in United States, United Kingdom and Kenya. K. Squires's co-authors include Henry W. Murray, M J McElrath, Robert D. Schreiber, Berish Y. Rubin, S. Anderson, Mark Y. Stoeckle, Christian Bogdan, Angela Granelli‐Piperno, Gary C. Kanel and Chun‐Hua Wang and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

K. Squires

22 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Squires United States	17	467	446	309	259	131	22	948
A Sánchez-Quijano Spain	18	531 1.1×	1.1k 2.6×	251 0.8×	337 1.3×	184 1.4×	52	1.7k
Manuel Crespo Spain	16	647 1.4×	296 0.7×	102 0.3×	423 1.6×	266 2.0×	40	927
María Stella Mura Italy	16	394 0.8×	349 0.8×	55 0.2×	169 0.7×	148 1.1×	31	826
Patrick Miailhes France	24	383 0.8×	995 2.2×	148 0.5×	134 0.5×	69 0.5×	82	1.4k
Josep M. Gatell Spain	22	991 2.1×	780 1.7×	66 0.2×	575 2.2×	233 1.8×	61	1.6k
George Perez United States	15	413 0.9×	353 0.8×	45 0.1×	169 0.7×	143 1.1×	36	785
Herman G. Sprenger Netherlands	13	624 1.3×	223 0.5×	46 0.1×	391 1.5×	396 3.0×	41	994
Leo Flamholc Sweden	17	487 1.0×	413 0.9×	97 0.3×	370 1.4×	99 0.8×	39	875
Sigal Yawetz United States	14	340 0.7×	234 0.5×	131 0.4×	130 0.5×	159 1.2×	26	656
Teresa Bini Italy	17	622 1.3×	278 0.6×	49 0.2×	442 1.7×	313 2.4×	65	962

Countries citing papers authored by K. Squires

Since Specialization

Citations

This map shows the geographic impact of K. Squires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Squires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Squires more than expected).

Fields of papers citing papers by K. Squires

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Squires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Squires. The network helps show where K. Squires may publish in the future.

Co-authorship network of co-authors of K. Squires

This figure shows the co-authorship network connecting the top 25 collaborators of K. Squires. A scholar is included among the top collaborators of K. Squires based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Squires. K. Squires is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Markowitz, Martin, Andrew Zolopa, K. Squires, et al.. (2014). Phase I/II study of the pharmacokinetics, safety and antiretroviral activity of tenofovir alafenamide, a new prodrug of the HIV reverse transcriptase inhibitor tenofovir, in HIV-infected adults. Journal of Antimicrobial Chemotherapy. 69(5). 1362–1369. 103 indexed citations

Hermes, Ashwaq, K. Squires, Linda Fredrick, et al.. (2012). Meta-Analysis of the Safety, Tolerability, and Efficacy of Lopinavir/Ritonavir-Containing Antiretroviral Therapy in HIV-1–Infected Women. HIV Clinical Trials. 13(6). 308–323. 9 indexed citations

Squires, K., et al.. (2010). Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE study. Journal of Antimicrobial Chemotherapy. 66(2). 363–370. 30 indexed citations

Garland, Wendy, Amy Rock Wohl, Mallory D. Witt, et al.. (2007). The acceptability of a directly-administered antiretroviral therapy (DAART) intervention among patients in public HIV clinics in Los Angeles, California. AIDS Care. 19(2). 159–167. 16 indexed citations

Colonno, Richard J., et al.. (2006). The effects of the Roche AMPLICOR HIV-1 MONITOR® UltraSensitive Test versions 1.0 and 1.5 viral load assays and plasma collection tube type on determination of response to antiretroviral therapy and the inappropriateness of cross-study comparisons. Journal of Clinical Virology. 35(4). 420–425. 16 indexed citations

Wohl, Amy Rock, Wendy Garland, K. Squires, et al.. (2006). A Randomized Trial of Directly Administered Antiretroviral Therapy and Adherence Case Management Intervention. Clinical Infectious Diseases. 42(11). 1619–1627. 74 indexed citations

Wohl, David A., Michelle A. Kendall, Susan Owens, et al.. (2005). The Safety of Discontinuation of Maintenance Therapy for Cytomegalovirus (CMV) Retinitis and Incidence of Immune Recovery Uveitis Following Potent Antiretroviral Therapy. HIV Clinical Trials. 6(3). 136–146. 28 indexed citations

Verma, Sumita, Chun‐Hua Wang, Sugantha Govindarajan, et al.. (2005). Do Type and Duration of Antiretroviral Therapy Attenuate Liver Fibrosis in HIV--Hepatitis C Virus--Coinfected Patients?. Clinical Infectious Diseases. 42(2). 262–270. 66 indexed citations

Lustgarten, Stephanie, K. Squires, Edward P. Acosta, et al.. (2004). Triple nucleoside analogue vs. efavirenz-containing regimens for the initialtreatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095. 32–43. 11 indexed citations

10.

Hirsch, Martin, Roy T. Steigbigel, S Staszewski, et al.. (2003). Long-Term Efficacy, Safety, and Tolerability of Indinavir-Based Therapy in Protease Inhibitor--Naive Adults with Advanced HIV Infection. Clinical Infectious Diseases. 37(8). 1119–1124. 13 indexed citations

11.

Feldman, Joseph, Stephen J. Gange, Peter Bacchetti, et al.. (2003). Serum Albumin Is a Powerful Predictor of Survival Among HIV-1–Infected Women. JAIDS Journal of Acquired Immune Deficiency Syndromes. 33(1). 66–73. 56 indexed citations

12.

Huang, Weijie, Victor De Gruttola, Margaret A. Fischl, et al.. (2001). Patterns of Plasma Human Immunodeficiency Virus Type 1 RNA Response to Antiretroviral Therapy. The Journal of Infectious Diseases. 183(10). 1455–1465. 33 indexed citations

13.

Broker, Thomas R., M. Richardson, K. Squires, et al.. (1998). MOLECULAR EPIDEMIOLOGY OF HPV INFECTIONS OF THE FEMALE GENITAL TRACT, IDENTIFIED BY A NOVEL PCR/RESTRICTION/SEQUENCING ANALYSIS OF RENAL TRANSPLANT CANDIDATES & RECIPIENTS AND OF HIV-POSITIVE PATIENTS.. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A13–A13. 1 indexed citations

14.

Vanhove, Geertrui F., Helen Kastrissios, Davide Verotta, et al.. (1997). Pharmacokinetics of saquinavir, zidovudine, and zalcitabine in combination therapy. Antimicrobial Agents and Chemotherapy. 41(11). 2428–2432. 25 indexed citations

15.

Murray, Henry W., K. Squires, Wolfgang Weiß, et al.. (1995). Stavudine In Patients With Aids And Aids-Related Complex: Aids Clinical Trials Group 089. The Journal of Infectious Diseases. 171(Supplement 2). S123–S130. 42 indexed citations

16.

Dudley, Michael N., et al.. (1995). Population pharmacokinetics of stavudine (d4T) in patients with AIDS or advanced AIDS-related complex. Antimicrobial Agents and Chemotherapy. 39(10). 2309–2315. 36 indexed citations

17.

Squires, K., et al.. (1993). Immunochemotherapy for Visceral Leishmaniasis: a Controlled Pilot Trial of Antimony Versus Antimony Plus Interferon-Gamma. American Journal of Tropical Medicine and Hygiene. 48(5). 666–669. 57 indexed citations

18.

Nathan, Carl, K. Squires, William R. Levis, et al.. (1990). Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon gamma.. The Journal of Experimental Medicine. 172(5). 1509–1512. 25 indexed citations

19.

Squires, K., et al.. (1989). Interferon- and Mycobacterium avium-intracellulare Infection. The Journal of Infectious Diseases. 159(3). 599–600. 41 indexed citations

20.

Squires, K., Robert D. Schreiber, M J McElrath, et al.. (1989). Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response.. The Journal of Immunology. 143(12). 4244–4249. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact